HIGHLIGHTS
- who: Maria Guadalupe Martinez and colleagues from the INSERM, CNRS UMR-5286, Cancer Research Center of Lyon (CRCL), Lyon, France have published the article: Gene Editing Technologies to Target HBV cccDNA, in the Journal: Viruses 2022, 2654 of /2022/
- future: Recent studies have shown no spurious RNA or DNA deamination in the case of ABE base editors although more work will be necessary to evaluate ABEs for particular therapeutic applications . More studies will be necessary to evaluate their clinical relevance.
SUMMARY
Lentiviral_vectors were used in the past for the expression of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.